Literature DB >> 8654566

Basal phosphorylation of mu opioid receptor is agonist modulated and Ca2+-dependent.

Z Wang1, J Arden, W Sadée.   

Abstract

The mu opioid receptor was shown to be phosphorylated at a basal rate in the absence of agonist, measured in permeabilized HEK293 cells transfected with an epitope tagged mu receptor (EE-mu) [Arden, J., Segredo, V., Wang, Z., Lameh, J. and Sadee, W. (1995) J. Neurochem. 65, 1636-1645]. In the present study, basal phosphorylation was found to be Ca2+ dependent; however, several inhibitors of protein kinase C and Ca2+-calmodulin dependent kinases failed to affect basal mu receptor phosphorylation. Thus, the basal mu receptor phosphorylating activity differed from the main kinases involved in receptor regulation. The general kinase inhibitor H7 (100 microM) suppressed basal mu receptor phosphorylation. Pretreatment with the agonist morphine, followed by drug removal, resulted in a sustained increase of basal mu receptor phosphorylation. The gradual agonist dependent modulation of basal mu receptor phosphorylation suggests a novel regulatory mechanism which may play a role in narcotic tolerance and dependence.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654566     DOI: 10.1016/0014-5793(96)00467-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

Review 1.  Post-transcriptional regulation of opioid receptors in the nervous system.

Authors:  Li-Na Wei; Ping-Yee Law; Horace H Loh
Journal:  Front Biosci       Date:  2004-05-01

2.  Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Molecular modeling of G-protein coupled receptor kinase 2: docking and biochemical evaluation of inhibitors.

Authors:  M U Kassack; P Högger; D A Gschwend; K Kameyama; T Haga; R C Graul; W Sadée
Journal:  AAPS PharmSci       Date:  2000

4.  Genetic alteration of phospholipase C beta3 expression modulates behavioral and cellular responses to mu opioids.

Authors:  W Xie; G M Samoriski; J P McLaughlin; V A Romoser; A Smrcka; P M Hinkle; J M Bidlack; R A Gross; H Jiang; D Wu
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

5.  Orphanin FQ/nociceptin attenuates the development of morphine tolerance in rats.

Authors:  K Lutfy; S M Hossain; I Khaliq; N T Maidment
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

6.  Morphine withdrawal enhances constitutive μ-opioid receptor activity in the ventral tegmental area.

Authors:  Frank J Meye; Ruud van Zessen; Marten P Smidt; Roger A H Adan; Geert M J Ramakers
Journal:  J Neurosci       Date:  2012-11-14       Impact factor: 6.167

7.  The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptor-dependent synaptic plasticity.

Authors:  Keith A Trujillo
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

8.  Dissecting the roles of GRK2 and GRK3 in μ-opioid receptor internalization and β-arrestin2 recruitment using CRISPR/Cas9-edited HEK293 cells.

Authors:  Thor C Møller; Mie F Pedersen; Jeffrey R van Senten; Sofie D Seiersen; Jesper M Mathiesen; Michel Bouvier; Hans Bräuner-Osborne
Journal:  Sci Rep       Date:  2020-10-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.